CNH Partners »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by CNH Partners

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by CNH Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 16M 1.19
2024-06-30 $15M 14M 1.11
2024-03-31 $13M 14M 0.97
2023-12-31 $7.7M 8.2M 0.93

More positions owned by CNH Partners

Endeavor Group Hldgs Cl A Com (EDR)
Southwestern Energy Company
American Airls Put Option (AAL)
Stride Note 1.125% 9/0 (Principal)
American Airlines Group Note 6.500% 7/0 (Principal)
Microstrategy Cl A New Put Option (MSTR)
Championx Corp (CHX)
Sea Sponsord Ads Put Option (SE)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Dropbox Note 3/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Axonics Modulation Technolog (AXNX)
Interdigital Note 3.500% 6/0 (Principal)
Transocean Deb 4.625% 9/3 (Principal)

View all positions for CNH Partners

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1